Celgene aims to boost the effectiveness of its novel drug marizomib for aggressive brain tumour glioblastoma (GBM) by asking patients to wear a special cap. Marketed by Novocure, the Optune ...
Developed by Jersey, US-based Novocure, Optune beams so-called Tumour Treating Fields (TTFs) through the scalp and into brain tumours where they disrupt cell division. Because of the shifting ...
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback